VERADIGM INC. Form 8-K: Current report
Filings on SEC EDGAR, newest first; amendments sit with their base form. Values are as filed.
- 2017-12-28: Form 8-K; Period of report 2017-12-28; Description 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers; Details 5.02.
- 2017-12-15: Form 8-K/A; Period of report 2017-10-02; Description 9.01 Financial Statements and Exhibits; Details 9.01.
- 2017-11-09: Form 8-K/A; Period of report 2017-08-25; Description 9.01 Financial Statements and Exhibits; Details 9.01.
- 2017-11-02: Form 8-K; Period of report 2017-11-02; Description 2.02 Results of Operations and Financial Condition; Details 2.02.
| Filed | Form | Period of report | Description | Details | Document |
|---|---|---|---|---|---|
| 2017-12-28 | 8-K | 2017-12-28 | 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers | 5.02 As part of the ongoing integration of the Enterprise Information Solutions business (the “EIS Business”) that Allscripts Healthcare Solutions, Inc., a Delaware corporation (the “Company”), acquired from McKesson Corporation, a Delaware corporation, on October 2, 2017, the Company commenced a reorganization of its management team that resulted in, among other things, the management of certain solutions development functions being transitioned to other senior management employees of the Company. | d497723d8k.htm |
| 2017-12-15 | 8-K/A | 2017-10-02 | 9.01 Financial Statements and Exhibits | 9.01 (a) Financial statements of businesses acquired. | mdrx-8ka_20171002.htm |
| 2017-11-09 | 8-K/A | 2017-08-25 | 9.01 Financial Statements and Exhibits | 9.01 (a) Financial statements of businesses acquired. | mdrx-8ka_20170825.htm |
| 2017-11-02 | 8-K | 2017-11-02 | 2.02 Results of Operations and Financial Condition | 2.02 On November 2, 2017, Allscripts Healthcare Solutions, Inc. (the “Company”) issued a press release regarding the Company’s financial results for the three and nine months ended September 30, 2017. | f8k_110217.htm |
| 2017-10-02 | 8-K | 2017-10-02 | 2.01 Completion of Acquisition or Disposition of Assets; 7.01 Regulation FD Disclosure | 2.01 On October 2, 2017, Allscripts Healthcare, LLC, a North Carolina limited liability company (“Purchaser”) and wholly-owned subsidiary of Allscripts Healthcare Solutions, Inc., a Delaware corporation (“Allscripts”, “we”, “us” and “our”), completed the transactions contemplated by a purchase agreement (the “Purchase Agreement”) with McKesson Corporation, a Delaware corporation (“McKesson”), pursuant to which Purchaser purchased McKesson’s Enterprise Information Solutions (EIS) Business division (the “EIS Business”) by acquiring all of the outstanding equity interests of two indirect, wholly-owned subsidiaries of McKesson: (i) PF2 EIS LLC, a Delaware limited liability company, and (ii) PF2 Enterprise Information Solutions Canada ULC, an unlimited liability corporation organized under the laws of British Columbia. 7.01 On October 2, 2017, Allscripts issued a press release announcing the closing of the transaction described above under Item 2.01. | mdrx-8k_20171002.htm |
| 2017-08-31 | 8-K | 2017-08-25 | 2.01 Completion of Acquisition or Disposition of Assets | 2.01 On August 25, 2017, Allscripts Healthcare Solutions, Inc. (“Allscripts”) completed the transactions contemplated by an asset purchase agreement (the “APA”) with NantHealth, Inc. (“NantHealth”), pursuant to which Allscripts acquired substantially all of the assets of NantHealth’s provider/patient engagement solutions business, including NantHealth’s FusionFX solution and components of its NantOS software connectivity solutions (the “Business”). | d360607d8k.htm |
| 2017-08-04 | 8-K | 2017-08-01 | 1.01 Entry into a Material Definitive Agreement; 7.01 Regulation FD Disclosure | 1.01 On August 1, 2017, Allscripts Healthcare, LLC, a North Carolina limited liability company (“Purchaser”) and wholly-owned subsidiary of Allscripts Healthcare Solutions, Inc., a Delaware corporation (“Allscripts”), and McKesson Corporation, a Delaware corporation (“Seller Parent”), entered into a Purchase Agreement (the “Purchase Agreement”). 7.01 On August 3, 2017, Allscripts and Seller Parent issued a joint press release announcing the transaction described above under Item 1.01 of this Current Report on Form 8-K. A copy of the joint press release is attached hereto as Exhibit 99.1. | d434000d8k.htm |
| 2017-08-03 | 8-K | 2017-08-03 | 2.02 Results of Operations and Financial Condition | 2.02 On August 3, 2017, Allscripts Healthcare Solutions, Inc. (the “Company”) issued a press release regarding the Company’s financial results for the three and six months ended June 30, 2017. | f8k_080317.htm |
| 2017-05-24 | 8-K | 2017-05-22 | 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers; 5.07 Submission of Matters to a Vote of Security Holders; 7.01 Regulation FD Disclosure | 5.02 (e) At the Annual Meeting of Stockholders held on May 22, 2017, the stockholders of Allscripts Healthcare Solutions, Inc. (the “Company”) approved the second amendment and restatement of the Company’s 2011 Stock Incentive Plan (the “Second Amended and Restated 2011 Plan”), which had been previously approved by the Board of Directors, subject to stockholder approval. 7.01 On May 24, 2017, the Company issued a press release announcing the election of Mara G. Aspinall to serve as director. | mdrx-8k_20170522.htm |
| 2017-05-12 | 8-K | 2017-05-12 | 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers; 7.01 Regulation FD Disclosure | 5.02 On May 12, 2017, Allscripts Healthcare Solutions, Inc. (the “Company”) announced that Melinda D. Whittington would no longer be serving as Chief Financial Officer, principal financial officer or principal accounting officer of the Company, effective immediately. 7.01 On May 12, 2017, the Company issued a press release announcing Mr. Olis’s promotion to interim Chief Financial Officer of the Company. | d379905d8k.htm |
| 2017-05-04 | 8-K | 2017-05-04 | 2.02 Results of Operations and Financial Condition | 2.02 On May 4, 2017, Allscripts Healthcare Solutions, Inc. (the “Company”) issued a press release regarding the Company’s financial results for the three months ended March 31, 2017. | f8k_050417.htm |
| 2017-03-21 | 8-K | 2017-03-21 | 7.01 Regulation FD Disclosure | 7.01 As previously announced, on March 21, 2017, Allscripts Healthcare Solutions, Inc. (the “Company”) will be hosting an investor day event in New York City beginning at 8:00 am Eastern time (“Investor Day”). | mdrx-8k_20170321.htm |
| 2017-02-16 | 8-K | 2017-02-16 | 2.02 Results of Operations and Financial Condition | 2.02 On February 16, 2017, Allscripts Healthcare Solutions, Inc. (the “Company”) issued a press release regarding the Company’s financial results for the three months and year ended December 31, 2016. | f8k_021617.htm |
| 2017-01-11 | 8-K/A | 2016-10-27 | 9.01 Financial Statements and Exhibits | 9.01 (a) Financial statements of businesses acquired. | mdrx-8ka_20161027.htm |
| 2017-01-10 | 8-K | 2017-01-09 | 2.02 Results of Operations and Financial Condition; 7.01 Regulation FD Disclosure | 2.02 On January 9, 2017, Allscripts Healthcare Solutions, Inc. (the “Company”) issued a press release regarding the Company’s preliminary financial results for the fourth quarter ended December 31, 2016. 7.01 On January 10, 2017, the Company will present at the 35th Annual J.P. Morgan Healthcare Conference in San Francisco, California. | mdrx-8k_20170109.htm |